Results: 8
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 877, doi. 10.1007/s40264-021-01088-6
- By:
- Publication type:
- Article
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 825, doi. 10.1007/s40264-021-01083-x
- By:
- Publication type:
- Article
Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 853, doi. 10.1007/s40264-021-01081-z
- By:
- Publication type:
- Article
Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 863, doi. 10.1007/s40264-021-01080-0
- By:
- Publication type:
- Article
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 843, doi. 10.1007/s40264-021-01078-8
- By:
- Publication type:
- Article
The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 835, doi. 10.1007/s40264-021-01074-y
- By:
- Publication type:
- Article